Inflammatory bowel disease and osteoporosis.
The relation between inflammatory bowel disease (IBD) and osteoporosis has received increasing attention during the past decade. The prevalence of low bone mass in patients with IBD has been reported to be more than 50%. The development of a quick non-invasive method to diagnose osteoporosis (dual-energy X-ray absorptiometry) provides a practical tool to identify the patient who needs special attention. The aetiology of the bone disease in patients with IBD has still not been elucidated, but corticosteroids may play a major role. Studies on the prevention/treatment of IBD-related osteoporosis are scarce. In a single uncontrolled study hormone replacement therapy proved effective in preventing bone loss in peri- and post-menopausal women with IBD. A placebo-controlled study showed that supplementation with calcium and vitamin D prevents bone loss in patients with Crohn's disease. The present paper reviews our current knowledge on the mechanisms and epidemiology of IBD-related bone disease.
Andreassen
H
H
Dept. of Internal Medicine, Roskilde Amtssygehus, Køge, Denmark.
Rungby
J
J
Dahlerup
J F
JF
Mosekilde
L
L
D015519:Bone Density; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000473:pathology; D010018:Osteomalacia / Q000150:complications / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D014807:Vitamin D / Q000502:physiology
D014807:Vitamin D